Endovab’s mission is to develop and provide innovative endovascular tools and techniques that improve vascular treatments through research and clinical experience.
Endovab was founded in 2009 and has its head office in Stockholm and a research laboratory in Uppsala. The company’s founder and innovation lead MD, Ph.D. Krister Liungman, Head of Vascular Surgery at Uppsala University Hospital, has more than 25 years of experience in treating vascular disease.
With experienced backers and a driven team, Endovab is committed to its objective of improving treatment within the field of endovascular surgery.
Company’s Keywords:
<3
<
<2009
Your request has been submitted successfully.
Own or work here?